A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
- PMID: 30117265
- PMCID: PMC6209538
- DOI: 10.1002/ajmg.c.31637
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
Abstract
Tuberous sclerosis complex (TSC) is associated with a wide range of behavioral, psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties, which are often underdiagnosed and undertreated. Here, we present a clinical update on TSC-associated neuropsychiatric disorders, abbreviated as "TAND," to guide screening, diagnosis, and treatment in practice. The review is aimed at clinical geneticists, genetic counselors, pediatricians, and all generalists involved in the assessment and treatment of children, adolescents and adults with TSC, and related disorders. The review starts with a summary of the construct and levels of TAND, before presenting up-to-date information about each level of investigation. The review concludes with a synopsis of current and future TAND research.
Keywords: ADHD; TANDTSC; anxiety; autism spectrum disorder; behavior; depression; mental health; neuropsychological deficits; scholastic difficulties.
© 2018 The Authors. American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals, Inc.
Similar articles
-
TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.Orphanet J Rare Dis. 2018 Sep 10;13(1):157. doi: 10.1186/s13023-018-0901-8. Orphanet J Rare Dis. 2018. PMID: 30201051 Free PMC article.
-
The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.Orphanet J Rare Dis. 2020 Sep 7;15(1):237. doi: 10.1186/s13023-020-01488-4. Orphanet J Rare Dis. 2020. PMID: 32894194 Free PMC article.
-
Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?Pediatr Neurol. 2018 Apr;81:38-44. doi: 10.1016/j.pediatrneurol.2017.12.006. Epub 2018 Jan 31. Pediatr Neurol. 2018. PMID: 29530301
-
[Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):139-153. doi: 10.1024/1422-4917/a000604. Epub 2018 Aug 6. Z Kinder Jugendpsychiatr Psychother. 2019. PMID: 30080117 Review. German.
-
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).J Neurodev Disord. 2023 Sep 14;15(1):32. doi: 10.1186/s11689-023-09500-1. J Neurodev Disord. 2023. PMID: 37710171 Free PMC article.
Cited by
-
Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex.Front Neurol. 2022 May 24;13:863826. doi: 10.3389/fneur.2022.863826. eCollection 2022. Front Neurol. 2022. PMID: 35685742 Free PMC article.
-
Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties: Insights from Clinical Practice.J Neuromuscul Dis. 2024;11(4):791-799. doi: 10.3233/JND-230251. J Neuromuscul Dis. 2024. PMID: 38701157 Free PMC article.
-
Shared mechanisms of neural circuit disruption in tuberous sclerosis across lifespan: Bridging neurodevelopmental and neurodegenerative pathology.Front Genet. 2022 Nov 25;13:997461. doi: 10.3389/fgene.2022.997461. eCollection 2022. Front Genet. 2022. PMID: 36506334 Free PMC article. Review.
-
Abnormal White Matter Microstructure in the Limbic System Is Associated With Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders.Front Neurol. 2022 Mar 14;13:782479. doi: 10.3389/fneur.2022.782479. eCollection 2022. Front Neurol. 2022. PMID: 35359647 Free PMC article.
-
Reading Ability in Patients With Tuberous Sclerosis Complex: Results of Chinese Character Reading and Reading Comprehension Tests.Front Psychol. 2022 May 13;13:849334. doi: 10.3389/fpsyg.2022.849334. eCollection 2022. Front Psychol. 2022. PMID: 35645943 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatric Disorders. 5. Arlington, VA: American Psychiatric Publishing; 2013.
-
- Asato MR, Hardan AY. Neuropsychiatric problems in tuberous sclerosis complex. Journal of Child Neurology. 2004;19(4):241–249. - PubMed
-
- Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, … Budde K. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. 2013;381(9869):817–824. doi: 10.1016/S0140-6736(12)61767-X. - DOI - PubMed
-
- Bolton PF, Park RJ, Higgins JNP, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002;125(6):1247–1255. - PubMed
Publication types
MeSH terms
Grants and funding
- Novartis/International
- Curemark, LLC/International
- Texas Higher Education Coordinating Board (THECB)/International
- Cerebra Centre for Neurodevelopmental Disorders/International
- National Research Foundation/International
- Health Resources and Service Administration (HRSA)/International
- T73MC22236/Leadership Education in Neurodevelopmental and Related Disorders (LEND)/International
- 602391/EPISTOP/International
- U01 NS092595/NS/NINDS NIH HHS/United States
- U54 NS092090/NS/NINDS NIH HHS/United States
- NS082320/NH/NIH HHS/United States
- U01 NS082320/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical